Antibody discovery workflow

#Antibody discovery workflow #Antibody-based therapeutics #Biologics #Monoclonal antibodies

Biologics developability: How Merck creates developability profiles for their mAbs

In this Application Note, discover how the Protein Sciences group at Merck & Co. builds developability profiles for their monoclonal antibody variants. Get an in-depth explanation of the experiments they set up to obtain parameters that help them decide which candidates have the best potential to reach the market, and how they… Read More

#Resources

#Antibodies #Antibody discovery workflow #Therapeutic Antibodies #Twist Bioscience

Every day matters

This paid-for advertorial by Twist Bioscience appeared in the Therapeutic Antibodies Guide – DDW Volume 25 – Issue 1, Winter 2023/2024 Improving gene synthesis speed can reduce workflow times, saving you invaluable time, says Twist Bioscience. Time can mean more than money when you’re studying a deadly pathogen. The importance of speed and… Read More

#Exclusive Content

Antibodies
#Antibodies #Antibody discovery workflow #Antibody drug conjugate (ADC) #CAR-T #Therapeutic Antibodies

Fortis Life Sciences leads the way in custom antibody discovery

This article is sponsored by Fortis Life Sciences. In the ever-evolving landscape of therapeutic development, the role of antibodies has become increasingly apparent. Antibodies are used as therapeutics, components of therapeutics such as antibody-drug conjugates (ADC) and CAR-T cells, and as companion diagnostic tools. Fortis Life Sciences offers… Read More

#News

PEGS Europe posters
#Antibodies #Antibody discovery workflow #Biologics #Drug discovery #Events #PEGS Europe 2023 #Protein engineering

Reflecting on PEGS Europe 2023 

DDW’s Megan Thomas attended PEGS Europe 2023 in Lisbon, Portugal, from Tuesday 14 November to Thursday 16 November 2023. Here, she shares insight from the annual biologics technology meeting.   Scientific tracks and presentations  Antibody-based cancer therapies   The first presentation attended in the antibody-based cancer therapies track, within the antibody drug… Read More

#Exclusive Content

Two scientists working in a lab
#Antibody discovery workflow #Biotherapeutics #Cell line development #Cell lines #Drug development #Large molecules

Advancements in upstream CLD for enhanced biotherapeutics production

This article is sponsored by Revvity. By Anis H Khimani, PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. As the significance of large molecules continues to broaden across diverse modalities, emphasis… Read More

#Exclusive Content

#Antibodies #Antibody #Antibody discovery workflow #Antibody-based therapeutics #Bethyl Laboratories #Drug discovery

Why choose Bethyl antibodies for your R&D

This article is sponsored by Bethyl Laboratories. For over 50 years, Bethyl Laboratories (now a Fortis Life Sciences brand) has been dedicated to improving lives by supporting scientific discovery through qualified antibody products and custom services. We are vertically-integrated from immunisation through manufacturing and validation. All of our antibodies are… Read More

#News

IgE antibodies
#Allergy #Antibody discovery workflow #Engineered antibodies #Genomics #IgE antibodies #Immunotherapy #Monoclonal antibodies

Harnessing the power of IgE antibodies to create novel therapeutics

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies. By reengineering key antibodies in the allergic cascade, this biotech company is developing a first-in-class therapy for the millions of people whose daily lives are limited by food… Read More

Webinar date:
Brought to you by SPT Labtech
#Webinars

#Antibody discovery workflow #B cell diversity #Monoclonal antibodies

Accessing broad B cell diversity to rapidly identify high-value rabbit monoclonal antibodies

Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward screening of B cells in under one week. This presentation will introduce Berkeley Lights’ newest antibody discovery workflow, the Opto Memory B Discovery workflow, and share how customers are using the… Read More

Webinar date:
Brought to you by Berkeley Lights
#Webinars

IgE antibody
#Allergy #Antibody discovery workflow #Engineered antibodies #Genomics #IgE antibodies #Immunotherapy #Monoclonal antibodies

Exclusive webinar: Harness the power of IgE antibodies

Watch the webinar Harnessing the power of IgE antibodies to create novel therapeutics supported by SPT Labtech. From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies. By reengineering key antibodies in the allergic cascade, this… Read More

Webinar date:
Brought to you by SPT Labtech
#Editor's Choice #News

Antibodies attacking virus
#Antibody discovery workflow #B cell diversity #Monoclonal antibodies

Last chance to register: How to accelerate antibody discovery

Download the webinar Accessing Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies. Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward screening of B cells in under one week. Anupam Singhal, Director of Product Management,… Read More

Webinar date:
Brought to you by Berkeley Lights
#Editor's Choice #News

IgE antibody
#Allergy #Antibody discovery workflow #Engineered antibodies #Genomics #IgE antibodies #Immunotherapy #Monoclonal antibodies

The power of IgE antibodies in creating novel therapeutics

Watch the webinar Harnessing the power of IgE antibodies to create novel therapeutics supported by SPT Labtech. From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies. By reengineering key antibodies in the allergic cascade, this… Read More

Webinar date:
Brought to you by SPT Labtech
#News

Antibodies
#Antibody discovery workflow #B cell diversity #Monoclonal antibodies

Learn how to accelerate antibody discovery: webinar

Download the exclusive event: Accessing Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies. Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward screening of B cells in under one week. Anupam Singhal, Director of… Read More

Webinar date:
Brought to you by Berkeley Lights
#Editor's Choice #News

IgE antibodies
#Allergy #Antibody discovery workflow #Engineered antibodies #Genomics #IgE antibodies #Immunotherapy #Monoclonal antibodies

Learn how to harness the power of IgE antibodies

Watch the webinar Harnessing the power of IgE antibodies to create novel therapeutics supported by SPT Labtech. From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies. By reengineering key antibodies in the allergic cascade, this… Read More

Webinar date:
Brought to you by SPT Labtech
#News

Antibodies
#Antibody discovery workflow #B cell diversity #Monoclonal antibodies

Exclusive webinar: how to accelerate antibody discovery

Download the exclusive free event: Accessing Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies. Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward screening of B cells in under one week. Anupam Singhal, Director… Read More

Webinar date:
Brought to you by Berkeley Lights
#Editor's Choice #News

IgE antibodies
#Allergy #Antibody discovery workflow #Engineered antibodies #Genomics #IgE antibodies #Immunotherapy #Monoclonal antibodies

Harnessing the power of IgE antibodies to create novel therapeutics

Watch the webinar Harnessing the power of IgE antibodies to create novel therapeutics supported by SPT Labtech. From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies. By reengineering key antibodies in the allergic cascade, this biotech… Read More

Webinar date:
Brought to you by SPT Labtech
#News

#Antibody discovery workflow #B cell diversity #Monoclonal antibodies

How to accelerate the discovery of novel antibodies for drug discovery

Download the exclusive free webinar: Accessing Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies. Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward screening of B cells in under one week. Anupam Singhal, Director… Read More

Webinar date:
Brought to you by Berkeley Lights
#Editor's Choice #News